JDD Podcast: Ask the Investigator

← JDD Podcast: Ask the Investigator19 jun · 40 min

From Endpoint to Exam Room: Understanding What Psoriasis Trials Really Tell Us

From Endpoint to Exam Room: Understanding What Psoriasis Trials Really Tell Us19 jun40 min

<p>The post <a href="https://jddonline.com/dual-therapy-for-atopic-dermatitis-lebrikizumab-and-jak-inhibitors-used-in-tandem-for-treatment-resistant-cases-2/">From Endpoint to Exam Room: Understanding What Psoriasis Trials Really Tell Us</a> appeared first on <a href="https://jddonline.com">JDDonline - Journal of Drugs in Dermatology</a>.</p>